New approaches to disease treatment and prevention, as well as failures in old approaches are part of what we’re reading this week . . . NIH-Funded analysis estimates effective PrEP dosing for men who have sex with men: An analysis of data from the iPrEx study looked at the amount of the antiretroviral medicine […]
Congress Poised to Pass Budget Bill to Keep Government Running Until Next Spring Congress is back in town but is unlikely to stay long as members consider a bill to fund federal government programs for 6 months – until March 27, 2013. Passing this bill is essential to avoid a government shutdown on October 1—the […]
As board members of the Global Fund to Fight AIDS, Tuberculosis and Malaria prepare to meet Thursday and Friday in Geneva, advocates for tuberculosis detection, treatment and prevention have signed a response to a proposal they say will foster a divisive “disease against disease” approach to funding, and seriously undermine efforts to roll out cost-effective […]
Tuberculosis, Drug Resistance, and the History of Modern Medicine: From what may have been the first published randomized clinical drug trial, to neglect when deaths declined in the affluent countries where “headlines are written,” to the widening fault lines that divided those who had to worry about tuberculosis, and those who could ignore it, to […]
The vaccine that showed a vaccine can prevent HIV infection also has shown that the vaccine changed the virus in people who did become infected, according to research revealed today in the first plenary session of AIDS Vaccine 2012. The findings were the third revelation from a study that first generated excitement in the AIDS […]
BOSTON, MA — When Bill Snow, now director of the Global HIV Vaccine Enterprise, first became interested in the quest for a vaccine against the AIDS virus, he had a life expectancy of less than 10 years, he said Sunday. That was in 1989, he told the audience gathered for the opening of AIDS Vaccine […]
More than 30 years into the epidemic that was first documented among gay men in America, a disturbing trend is being noted globally: Where rates of new HIV infections are going down among other populations, they are rising among men who have sex with men. “The epidemics are going in different directions,” said Chris Beyrer […]
With a completed trial in Thailand that offered evidence a vaccine could be developed to protect people from HIV, emerging science identifying antibodies against HIV, and a current trial testing a novel vaccine combination against the virus potentially producing more information in the next year, this is an exciting time to hold a conference, organizers […]
Resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: This Lancet article looking at rates of resistance to second line anti-tuberculosis drugs in Estonia, Latvia, Peru, Phillipines, Russia, South Africa, South Korea and Thailand, put numbers on a situation already known: tuberculosis is growing harder to cure. Following a June New England […]
While the Global Fund to Fight AIDS Tuberculosis and Malaria looked at ways to restructure how it awards and administers grants, the Global Fund Board delegation representing nongovernmental organizations in developing countries conducted its own survey of obstacles in the field that have hindered the best use of those grants. The result was a report […]
HIV
By Felix Chinguwo A two-year program in Malawi aims to educate people, especially men and boys, about HIV, reduce transmission of the virus, help people to […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Amir M. Mohareb, MD, Louise C. Ivers, MD, MPH, Rajesh T. Gandhi, MD, and Shahin Lockman, MD, MSc As the U.S. convenes a global COVID-19 […]